Abstract
This review presents a link between histamine and epilepsy and provides the experimental evidence available so far on the effect of histamine and histaminergic agents in various seizure models. Agents that deplete brain histamine potentiate experimental convulsions while those enhancing tend to have anticonvulsant effects. Such effects are shown to be mediated via H1 and / or H3 but not H2 receptors. Lately, a large number of selective ligands for H3-receptors have been developed. Antagonists of these receptors have shown encouraging anticonvulsant effects in animal models and hold promise for potential therapeutic applications.
Keywords: brain histamine, epilepsy, seizures, convulsions, antagonists
Current Neuropharmacology
Title: Histamine as an Anticonvulsant Inhibitory Neurotransmitter
Volume: 2 Issue: 4
Author(s): Divya Vohora, S. N. Pal and K. K. Pillai
Affiliation:
Keywords: brain histamine, epilepsy, seizures, convulsions, antagonists
Abstract: This review presents a link between histamine and epilepsy and provides the experimental evidence available so far on the effect of histamine and histaminergic agents in various seizure models. Agents that deplete brain histamine potentiate experimental convulsions while those enhancing tend to have anticonvulsant effects. Such effects are shown to be mediated via H1 and / or H3 but not H2 receptors. Lately, a large number of selective ligands for H3-receptors have been developed. Antagonists of these receptors have shown encouraging anticonvulsant effects in animal models and hold promise for potential therapeutic applications.
Export Options
About this article
Cite this article as:
Vohora Divya, Pal N. S. and Pillai K. K., Histamine as an Anticonvulsant Inhibitory Neurotransmitter, Current Neuropharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570159043359459
DOI https://dx.doi.org/10.2174/1570159043359459 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sugars that Glow in the Dark: Fluorescent Tagged Glucose Bioprobes and their Facilitation of the Drug Discovery Process
Current Medicinal Chemistry Purinergic Signalling and Neurological Diseases: An Update
CNS & Neurological Disorders - Drug Targets Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nerve System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Ultrasonic Assisted Synthesis, Biological Evaluation, and Molecular Docking of Chalcone-based 1,5-benzodiazepine as Potential Anticonvulsant Agents
Current Enzyme Inhibition Long-Term Effects of Hypoxia-Reoxygenation on Thioredoxins in Rat Central Nervous System
Current Pharmaceutical Design Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain
Current Topics in Medicinal Chemistry Lower K<sub>V</sub>7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia
CNS & Neurological Disorders - Drug Targets What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine The Role of Neuroimaging in Our Understanding of the Suicidal Brain
CNS & Neurological Disorders - Drug Targets Molecular Docking, Synthesis and CNS Activity of Some Novel 1, 4-Benzodiazepine Derivatives
Letters in Drug Design & Discovery Vascular Oxidative Stress and Mitochondrial Failure in the Pathobiology of Alzheimer’s Disease: A New Approach to Therapy
CNS & Neurological Disorders - Drug Targets Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
Current Neuropharmacology Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Current Medicinal Chemistry Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy
Current Medicinal Chemistry Pharmacological and Biological Activities of Benzazepines: An Overview
Current Bioactive Compounds Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Cofilin Rod Formation in Neurons Impairs Neuronal Structure and Function
CNS & Neurological Disorders - Drug Targets Structural Activity Relationship and Importance of Benzothiazole Derivatives in Medicinal Chemistry: A Comprehensive Review
Mini-Reviews in Organic Chemistry Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed
Current Pharmaceutical Design Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ]
Current Topics in Medicinal Chemistry